1. Home
  2. RLYB vs RGS Comparison

RLYB vs RGS Comparison

Compare RLYB & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$15.68

Market Cap

75.9M

Sector

Health Care

ML Signal

HOLD

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$29.50

Market Cap

72.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLYB
RGS
Founded
2018
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
75.9M
72.0M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
RLYB
RGS
Price
$15.68
$29.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
312.9K
7.2K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.24
EPS
N/A
0.89
Revenue
$858,000.00
$210,134,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$32.36
Revenue Growth
43.00
3.52
52 Week Low
$0.27
$18.23
52 Week High
$16.00
$31.50

Technical Indicators

Market Signals
Indicator
RLYB
RGS
Relative Strength Index (RSI) 74.89 63.86
Support Level $0.55 $28.97
Resistance Level $15.31 $30.59
Average True Range (ATR) 0.69 1.03
MACD 0.05 0.06
Stochastic Oscillator 71.13 100.00

Price Performance

Historical Comparison
RLYB
RGS

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: